Platelet shape change evoked by selective activation of P2X1 purinoceptors with α,β-methylene ATP

Thrombosis and Haemostasis

Volumn 85, Issue 2, 2001, Pages 303-308

  Rolf, M G ^a   Brearley, C A ^a   Mahaut Smith, M P ^a  

^a Department of Physiology ^*  (United Kingdom)

Author keywords

ATP; P2X receptors; Platelets; Purinoceptors; Shape change

Indexed keywords

ABCIXIMAB; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; APYRASE; CALCIUM ION; FIBRINOGEN RECEPTOR ANTAGONIST; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG INHIBITION; EVOKED RESPONSE; HUMAN; HUMAN CELL; LIGHT ABSORPTION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SECOND MESSENGER; THROMBOCYTE ACTIVATION; THROMBOCYTE LIFESPAN; THROMBOCYTE SHAPE;

EID: 0035129349     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615684     Document Type: Article

References (40)

1. Aggregation of blood platelets by adenosine diphosphate and its reversal
2. Receptors for ADP on human blood-platelets
3. Multiple P2 receptor subtypes on platelets: A new interpretation of their function
4. 1 receptors is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells
5. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
6. ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
7. Adenosine 5-diphosphate antagonists and human platelets: No evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors
8. i2 proteins
9. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
10. 1 receptor is necessary for adenosine 5′-diphosphate- induced platelet aggregation
11. Role of P2Y1 purinoceptor in ADP-induced platelet activation
12. 2T purinoceptors in human platelets
13. Purinoceptor-evoked calcium signalling in human platelets
14. 1 purinoceptors in human platelets and megakaryoblastic cell lines
15. 2X receptor for extracellular ATP
16. Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique
17. Molecular mechanisms of platelet activation
18. Characterization of P2X1 purinoreceptors on rat platelets: Effect of clopidogrel
19. Platelet metabolism and activation
20. Stability constants of metal-ion complexes
21. Clinical estimation and significance of calcium-ion concentrations in the blood
22. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets
23. 2+ indicators with greatly improved fluorescence properties
24. Inositol phosphates in the duckweed Spirodela polyrhiza L
25. ADP induces partial aggregation without shape change and potentiates collagen-induced aggregation in the absence of Gαq
26. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
27. 2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor
28. Properties of the human platelet ADP receptor which releases calcium from intracellular stores
29. Identification of competitive antagonists of the P2Y1 receptor
30. Diffferent sensitivities to pH of ATP-induced currents at four cloned P2X receptors
31. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex
32. Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo
33. 2+ activates phospholipase C
34. 3) receptor
35. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2
36. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response
37. 2+ thresholds and Ca- independent activation for shape-change and secretion
38. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways
39. 13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets
40. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase